Workspace

Mutation Evidence Board

Lung adenocarcinoma cohort / research-use review

Research workflow

Start here, then run analysis.

Use the sidebar for navigation. This panel only points to the next workflow step.

Run analysis

Start a cohort analysis or continue the latest evidence review.

The workflow is linear: run analysis, review mutation relevance signals, export a research report, then share the client view.

Top signal

EGFR L858R

EGFR/ERBB signalling

Review queue

5 matches

2 reports ready

Cohorts

3

Demo datasets loaded

3

Samples

136

Across de-identified cohorts

136

Signals

15

Mutation relevance rows

15

Review

88

Top-signal average

88

Top mutation signals

Ranked for review

Open trace

1. EGFR L858R

EGFR/ERBB signalling / EGFR inhibitor class

94

2. TP53 R175H

p53 tumour suppressor pathway / DNA damage response research marker

88

3. KRAS G12C

RAS/MAPK signalling / KRAS pathway inhibitor class

82

Hypotheses

Candidate shortlist

5 matches

1. EGFR inhibitor class

Linked to EGFR L858R

Report ready

2. KRAS / MEK pathway inhibition

Linked to KRAS G12D

Review

3. KRAS / MEK pathway inhibition

Linked to KRAS G12C

Review

Workflow actions

Cohort details

Lung adenocarcinoma demo cohort

Switch cohorts, check the input shape, and confirm what is ready for expert review.

Active cohort

Cohort

Lung adenocarcinoma demo cohort

Cancer type

Lung adenocarcinoma

Samples

48

Input

VCF / annotated mutation table

Candidate matches

5

Reports ready

2

Run health

Pipeline snapshot

Healthy

Success

60%

Avg run

177s

Review

1

Ingest

Healthy

Schema and cohort checks

Annotate

Healthy

Pathway and mutation tags

Score

Healthy

Mutation relevance signals

Rank

Degraded

Candidate hypothesis order

Report

Healthy

Evidence brief export

Pathway view

Relevance distribution

Hover a pathway to inspect the linked mutation, candidate class, and evidence tags.

Recent runs

Activity queue

Pipeline

Recent activity

  • Amir exported evidence report rep-0023

    18m ago

  • Amir completed cohort scoring run-2026-0142

    24m ago

  • Lim uploaded cohort BRCA-2026-05.csv

    2h ago

  • System queued retrospective benchmark bench-0037

    3h ago

Review boundary

Keep the evidence trail visible before export.

Research-use only. ONCOQ.TECH produces evidence-ranked mutation signals and drug-repurposing hypotheses for investigation. Outputs are not clinical recommendations and must be reviewed by qualified experts before any validation or downstream use.

Generate report